HKD 8.0
(-3.38%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 589.75 Million CNY | 126.07% |
2022 | 260.87 Million CNY | 278.86% |
2021 | 68.85 Million CNY | 215.99% |
2020 | 21.79 Million CNY | 808.72% |
2019 | 2.39 Million CNY | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | 469.16 Million CNY | 0.0% |
2024 Q1 | 469.16 Million CNY | -19.85% |
2023 Q1 | 507.51 Million CNY | 94.55% |
2023 FY | 589.75 Million CNY | 126.07% |
2023 Q4 | 589.75 Million CNY | 0.0% |
2023 Q3 | 589.75 Million CNY | 16.21% |
2023 Q2 | 507.51 Million CNY | 0.0% |
2022 Q2 | 122.73 Million CNY | 0.0% |
2022 Q1 | 122.73 Million CNY | 78.25% |
2022 FY | 260.87 Million CNY | 278.86% |
2022 Q4 | 260.87 Million CNY | 0.0% |
2022 Q3 | 260.87 Million CNY | 112.55% |
2021 Q4 | 68.85 Million CNY | 32.95% |
2021 FY | 68.85 Million CNY | 215.99% |
2021 Q1 | - CNY | -100.0% |
2021 Q3 | 51.79 Million CNY | 0.0% |
2020 Q4 | 21.79 Million CNY | 0.0% |
2020 FY | 21.79 Million CNY | 808.72% |
2019 FY | 2.39 Million CNY | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Uni-Bio Science Group Limited | 30.61 Million HKD | -1826.555% |
CK Life Sciences Int'l., (Holdings) Inc. | 4.27 Billion HKD | 86.198% |